Journal of Hematology & Oncology is an open access, peer-reviewed online journal that encompasses all aspects of hematology and oncology. Read more.
Aims and scope
Articles
-
-
m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis
-
Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy
-
Tumorigenesis, diagnosis, and therapeutic potential of exosomes in liver cancer
-
Simultaneously inactivating Src and AKT by saracatinib/capivasertib co-delivery nanoparticles to improve the efficacy of anti-Src therapy in head and neck squamous cell carcinoma
-
Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options
-
The effects of β-glucan on human immune and cancer cells
-
Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers
-
Ibrutinib and novel BTK inhibitors in clinical development
-
The diagnosis and management of NK/T-cell lymphomas
Experimental Hematology & Oncology
Submit your research to our companion journal, Experimental Hematology & Oncology
Editor's quote
"Journal of Hematology & Oncology provides a forum for top-quality research and is a leading title in hematology and oncology, with an Impact Factor ranked in Q1 in both categories. The journal also publishes reviews and research highlights from leading experts in the field. Research is shared with fast turnaround times in an open access format among laboratory scientists, physician scientists, hematologists and oncologists."
Prof Delong Liu, Editor-in-Chief, Journal of Hematology & Oncology
Celebrating a decade of the Journal of Hematology & Oncology
2018 marked the 10 year anniversary since the Journal of Hematology & Oncology published its first article. Over the past decade, the journal has established itself in the top quartile of journals in both its fields worldwide.
To mark this occasion, we're looking back at the journal's milestone achievements and highlighting some of the best content from the past 10 years.
Advertisement
-
Official journal of
-
Journal of Hematology & Oncology is the official journal of the Chinese American Hematologist and Oncologist Network.
-
- Editorial Board
- Sign up for article alerts and news from this journal
Follow
Annual Journal Metrics
-
Speed
37 days to first decision for reviewed manuscripts only
41 days to first decision for all manuscripts
79 days from submission to acceptance
15 days from acceptance to publication
Citation Impact
8.731 - 2-year Impact Factor
7.373 - 5-year Impact Factor
1.593 - Source Normalized Impact per Paper (SNIP)
2.960 - SCImago Journal Rank (SJR)
Usage
792,876 Downloads
376 Altmetric Mentions
On the blog
-
Breast Cancer Quiz 2019
30 September 2019
-
Sharing data for the benefit of children with cancer
09 September 2019
-
Blood Cancer Awareness Quiz
06 September 2019
Institutional membership
Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).
Funding your APC
Advertisement
